Patients with ARDs who received RTX demonstrated impaired humoral responses to RZV, compared with healthy controls and ...

Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that has completed Phase III pivotal trials for the treatment of lung infections resulting from S. aureus ...

Global Phase 2b clinical trial underway evaluating rhu-pGSN for the treatment of moderate to severe ARDS. NORTH BRUNSWICK, N.J., June 17, 2025 (GLOBE NEWSWIRE) -- BioAegis Therapeutics ...

The economic, commercial, and financial blockade that the United States has maintained against Cuba for more than six decades ...

Akebia Therapeutics had a strong US launch of Vafseo and Q1 revenues signal robust demand, but near-term profitability remains uncertain. Read more on AKBA stock here.

AstraZeneca signed a potential $5 billion research deal with Chinese drugmaker CSPC. Eli Lilly is buying Verve Therapeutics for $1 billion upfront plus a CVR potentially worth another $300 million.

Agitation/Aggression in PMS and other ASD-related patient subpopulations are the main focus of Oryzon’s VANDAM project included in the Med4Cure IPCEI project ...

During World War I, people actually got poisoned eating rhubarb leaves when food was scarce. The beautiful red stalks are ...

November 2024: It is announced that work is now expected to begin in January 2025. February 2025: Bangor Marine's Aran Blackbourne says that "outstanding legal issues" mean the expected start date for ...

The historic botanical splendor of India extends beyond beauty and its forests harbor medicinal treasures which are used by diverse tribes. The plants of India ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...